- Home
- Publications
- Publication Search
- Publication Details
Title
Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy
Authors
Keywords
-
Journal
Nature Communications
Volume 7, Issue -, Pages 11838
Publisher
Springer Nature
Online
2016-06-20
DOI
10.1038/ncomms11838
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pegylated liposomal doxorubicin in the management of ovarian cancer
- (2014) Nicoletta Staropoli et al. CANCER BIOLOGY & THERAPY
- nab-paclitaxel for the management of patients with advanced non-small-cell lung cancer
- (2014) Vera Hirsh Expert Review of Anticancer Therapy
- Albumin-Bound Paclitaxel: The Benefit of This New Formulation in the Treatment of Various Cancers
- (2014) M. Montana et al. JOURNAL OF CHEMOTHERAPY
- State-of-the-art in design rules for drug delivery platforms: Lessons learned from FDA-approved nanomedicines
- (2014) Charlene M. Dawidczyk et al. JOURNAL OF CONTROLLED RELEASE
- Emerging applications for ferumoxytol as a contrast agent in MRI
- (2014) Mustafa R. Bashir et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Theranostic Nanoparticles
- (2014) F. Chen et al. JOURNAL OF NUCLEAR MEDICINE
- A Modular Labeling Strategy for In Vivo PET and Near-Infrared Fluorescence Imaging of Nanoparticle Tumor Targeting
- (2014) C. Perez-Medina et al. JOURNAL OF NUCLEAR MEDICINE
- Cancer nanomedicines: closing the translational gap
- (2014) Alberto Gabizon et al. LANCET
- Imaging and Nanomedicine in Inflammatory Atherosclerosis
- (2014) W. J. M. Mulder et al. Science Translational Medicine
- Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
- (2013) Nicolas Bertrand et al. ADVANCED DRUG DELIVERY REVIEWS
- Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology
- (2013) U. Prabhakar et al. CANCER RESEARCH
- Treatment innovations for metastatic breast cancer: Nanoparticle albumin-bound (NAB) technology targeted to tumors
- (2013) Ana Lluch et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Cancer Nanomedicine: From Drug Delivery to Imaging
- (2013) E. K.-H. Chow et al. Science Translational Medicine
- Personalized Nanomedicine
- (2012) T. Lammers et al. CLINICAL CANCER RESEARCH
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile
- (2012) J. Hrkach et al. Science Translational Medicine
- Pegylated Liposomal Doxorubicin
- (2011) Sean T. Duggan et al. DRUGS
- Pharmacological basis of pegylated liposomal doxorubicin: Impact on cancer therapy
- (2011) Alberto Gabizon et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Quantitative CT Imaging of the Spatial and Temporal Distribution of Liposomes in a Rabbit Tumor Model
- (2009) Jinzi Zheng et al. MOLECULAR PHARMACEUTICS
- Standardized methods for the production of high specific-activity zirconium-89
- (2009) Jason P. Holland et al. NUCLEAR MEDICINE AND BIOLOGY
- Imaging in the era of molecular oncology
- (2008) Ralph Weissleder et al. NATURE
- Seven challenges for nanomedicine
- (2008) Wendy R. Sanhai et al. Nature Nanotechnology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now